Insider Transactions in Q2 2022 at Johnson & Johnson (JNJ)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 10
2022
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
SELL
Open market or private sale
|
Direct |
40,000
-9.48%
|
$6,920,000
$173.0 P/Share
|
|
Jun 10
2022
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+26.44%
|
$2,880,000
$72.54 P/Share
|
|
May 26
2022
|
Robert J Decker VP Corporate Controller |
SELL
Open market or private sale
|
Direct |
8,462
-35.35%
|
$1,523,160
$180.0 P/Share
|
|
May 26
2022
|
Robert J Decker VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
8,462
+26.12%
|
$609,264
$72.54 P/Share
|
|
Apr 21
2022
|
William Hait EVP, Chief EI and Med Officer |
SELL
Open market or private sale
|
Direct |
29,699
-3.57%
|
$5,434,917
$183.58 P/Share
|
|
Apr 21
2022
|
William Hait EVP, Chief EI and Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,699
+21.27%
|
$2,672,910
$90.44 P/Share
|
|
Apr 20
2022
|
Joseph J Wolk Exec VP, CFO |
SELL
Bona fide gift
|
Direct |
46
-0.06%
|
-
|